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Abstract
Background:  In recent years it has become clear that small non-coding RNAs function as
regulatory elements in bacterial virulence and bacterial stress responses. We tested for the
presence of the small non-coding GcvB RNAs in Y. pestis as possible regulators of gene expression
in this organism.
Results: In this study, we report that the Yersinia pestis KIM6 gcvB gene encodes two small RNAs.
Transcription of gcvB is activated by the GcvA protein and repressed by the GcvR protein. The
gcvB-encoded RNAs are required for repression of the Y. pestis dppA gene, encoding the
periplasmic-binding protein component of the dipeptide transport system, showing that the GcvB
RNAs have regulatory activity. A deletion of the gcvB gene from the Y. pestis KIM6 chromosome
results in a decrease in the generation time of the organism as well as a change in colony
morphology.
Conclusion: The results of this study indicate that the Y. pestis gcvB gene encodes two small non-
coding regulatory RNAs that repress dppA expression. A gcvB deletion is pleiotropic, suggesting
that the sRNAs are likely involved in controlling genes in addition to dppA.
Background
Yersinia pestis is the causative agent of plague, an infec-
tious disease that results in lymphatic and blood infec-
tions [1]. The Y. pestis genome has been sequenced [2,3].
Y. pestis carries three plasmids of approximately 9.5, 70,
and 100 kilobasepairs and each carries genes necessary for
or that contribute to the pathogenicity of the bacterium
[1]. The 70 kilobasepair plasmid encodes the low-calcium
response stimulon (LCRS). Components of the LCRS
include Yops (secreted anti-host proteins) and a type III
secretion apparatus, or Ysc. The type III secretion appara-
tus is responsible for the translocation of the Yops to host
cells that in turn down-regulate the response of the host
phagocytic cells to infection [4]. Natural LCRS-negative
mutants of Y. pestis occur, resulting in avirulence of the
bacteria [1]. Besides the three plasmids, another patho-
genicity factor is pigmentation. Cells of Y. pestis adsorb
hemin at 26°C but not at 37°C and are pigmented
(Pgm+) and virulent. Spontaneous nonpigmented (Pgm-)
mutants of Y. pestis have been isolated. The Yersiniabactin
iron transport system is part of the pgm locus, and its loss
results in a Pgm- mutant that is avirulent in mice unless
hemin, ferrous sulfate, or ferric chloride is injected into
mice along with the bacterial challenge [1].
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Recently, a new class of molecules has been shown to reg-
ulate gene expression in bacteria, small non-coding regu-
latory RNAs (sRNAs). These sRNAs have gained much
attention as recent genome-wide studies have identified
sRNAs in a wide variety of organisms [5]. Most of these
bacterial sRNAs are between 50 and 400 nucleotides (nts)
in length and play important roles in global regulation
[6,7]. Hfq is a small RNA binding protein and sRNAs in
particular are targets for Hfq [6]. Binding of these sRNAs
by Hfq in some way facilitates base pairing between the
sRNAs and their respective target RNAs [8,9]. In Vibrio
cholerae, sRNAs (Qrr RNAs) have been shown to regulate
virulence genes [10] and in Brucella abortus an hfq muta-
tion is lethal [9]. These results suggest that sRNAs and Hfq
likely play important roles in the virulence of certain
Gram-negative pathogens.
The E. coli gcvB gene encodes sRNAs that are not translated
in vivo [11]. A strain carrying a deletion of gcvB has consti-
tutive synthesis of OppA and DppA, periplasmic binding
proteins of the two major peptide transport systems nor-
mally repressed in cells grown in rich medium [12-14]. In
addition to OppA and DppA, several other proteins were
shown to increase or decrease in response to GcvB RNA
levels, but the specific proteins were not identified [11].
Nevertheless, the results show that the GcvB RNAs are reg-
ulatory and possibly serve as global regulators. A compu-
ter search of the Y. pestis sequence showed that Y. pestis has
a gcvB gene that shares considerable sequence homology
with the E. coli gcvB sequence (Fig. 1). Thus, the GcvB
RNAs from E. coli likely have functional counterparts in Y.
pestis. The results of this study show that the Y. pestis gcvB
gene encodes two sRNAs that, in turn, have regulatory
activity. In addition, a deletion of the gcvB gene from the
Y. pestis chromosome alters growth rate and colony mor-
phology.
Results and discussion
Identification of the Y. pestis gcvB gene
The E. coli gcvB gene is divergently transcribed from gcvA,
which encodes the activator protein for gcvB expression
(Fig. 1) [11]. Thus, we used computer searches of genome
Comparison of the E. coli and Y. pestis gcvA/gcvB control regions and gcvB genes Figure 1
Comparison of the E. coli and Y. pestis gcvA/gcvB control regions and gcvB genes. Ec, E. coli; Yp, Y. pestis. Bases that are identical 
are boxed in gray. The E. coli promoter -10 and -35 sequences are underlined for gcvA [29] and overlined for gcvB [11]. Arrows 
indicate transcription start sites and directions of transcription of gcvA and gcvB. The GcvA binding region is indicated above 
the sequence [30]. The deduced Y. pestis -10 and -35 promoter sequences are underlined for gcvA and overlined for gcvB, and 
the deduced GcvA binding site is indicated above the sequence. Two Rho-independent transcription terminators for the E. coli 
and Y. pestis gcvB genes are indicated by inverted arrows. The fusion points for transcriptional fusions gcvB+53::lacZ (TF-1), 
gcvB+164::lacZ (TF-2) and gcvB+251::lacZ (TF-3) are indicated by vertical arrows.
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sequences with the gcvA gene product as a query to predict
gcvB homologs in other organisms. We identified GcvB-
like RNA sequences in the genera Yersinia, Salmonella, Hae-
mophilus,  Vibrio,  Pasteurella,  Shigella, Erwinia, Klebsiella,
Photorhabdus  and  Actinobacillus. Despite considerable
sequence variation in many of these homologs, they are
predicted by the mfold algorithm [15] to assume a similar
secondary structure. A comparison of three of these GcvB
RNAs is shown in Fig. 2. The location of the putative Y.
pestis gcvB gene adjacent to and divergent from gcvA, its
77% sequence similarity to the E. coli gcvB sequence and
its predicted secondary structure make it a likely homolog
of gcvB in Y. pestis. Furthermore, identical gcvB sequences
can be found in all other Y. pestis strains presently in the
data base, both virulent and avirulent strains.
The Y. pestis gcvB gene encodes two sRNAs
The E. coli gcvB gene encodes two sRNA transcripts that are
not translated in vivo [11]. To determine if the gcvB gene
in Y. pestis is functional and possibly encodes sRNAs, we
initially constructed plasmid pgcvBYp+53::lacZ, carrying a
transcriptional fusion of the gcvB gene at basepair (bp)
+53 to lacZ. Plasmid pgcvBYp+53::lacZ and the vector alone
were transformed into Y. pestis strain KIM6, the transform-
ants grown in heart-infusion broth (HIB) + ampicillin
(AP) to mid-log phase of growth and the cultures assayed
for  β-galactosidase activity. The KIM6 and KIM6
[pMC1403] control transformant gave 6 ± 0.3 and 6 ± 1
units of β-galactosidase activity, respectively, whereas the
KIM6 [pgcvBYp+53::lacZ] transformant gave 5,985 ± 118
units of β-galactosidase activity. The results suggest that
the gcvB gene is expressed in Y. pestis.
The gcvB gene from Y. pestis possesses two possible Rho-
independent transcription terminators, which if func-
tional, would allow the production of two sRNAs of about
130 nts and 206 nts (Fig. 1). Three transcriptional gene
fusions of the Y. pestis gcvB gene to lacZ were created to
determine if these putative terminator sites function as
transcription terminators in vivo. The three fusions, desig-
nated  λgcvBYp+53::lacZ,  λgcvBYp+164::lacZ  and
λgcvBYp+251::lacZ, were used to lysogenize E. coli strain
GS162. The lysogens were then grown in Luria-Bertani
broth (LB) [16] to mid-log phase of growth and the cul-
tures assayed for β-galactosidase activity. About 44% of
the β-galactosidase activity seen when the fusion precedes
both terminators (λgcvBYp+53::lacZ) is lost when the fusion
point follows terminator t1 (λgcvBYp+164::lacZ), implicat-
ing t1 as a site of transcription termination in vivo (Table
1). The remaining activity that escapes termination by t1
is not seen in GS162λgcvBYp+251::lacZ, indicating t2 also
functions as a terminator in vivo (Table 1). When the 206
nts preceding terminator t2 for gcvB were analyzed, there
were only short open reading frames (ORFs) that could
encode polypeptides of 36 amino acids or less. These
ORFs all lack good translational start sites and were not
tested to determine if they encode small polypeptides. The
E. coli GcvB RNAs are not translated into polypeptides
[11]. Thus, we conclude that the products of the gcvB gene
in Y. pestis are two sRNAs that are not translated, although
Secondary structures of GcvB RNAs with 77% (Y. pestis) and 53% (V. cholerae) identity to the E. coli GcvB RNA as predicted by  the mfold algorithm [15] Figure 2
Secondary structures of GcvB RNAs with 77% (Y. pestis) and 53% (V. cholerae) identity to the E. coli GcvB RNA as predicted by 
the mfold algorithm [15].
E. coli  Y. pestis V. choleraeBMC Microbiology 2006, 6:52 http://www.biomedcentral.com/1471-2180/6/52
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the results do not completely rule out the possibility that
the Y. pestis GcvB sRNAs encode small peptides. In E. coli,
about 90% of the transcripts that initiate at the gcvB pro-
moter terminate at terminator t1, and the remaining 10%
terminate at terminator t2 [11]. A comparison of the E.
coli and Y. pestis t1 sites shows that an additional 2 bps
occur between the predicted GC-rich stem-loop structure
and the run of T residues in the Y. pestis t1 site that are not
present in the E. coli sequence, suggesting that the Y. pestis
t1 site is likely less functional as a transcription terminator
than the E. coli t1 site (Fig. 1). Nevertheless, the results are
consistent with the Y. pestis gcvB gene encoding two sRNA
molecules of about 130 and 206 nts and in roughly equal
amounts.
We used Northern blotting to confirm that the gcvB locus
in Y. pestis encodes sRNA transcripts of about 130 and 206
nts. Two small RNA molecules were detected in RNA iso-
lated from Y. pestis KIM6 grown in HIB medium using a
probe specific for the gcvB locus (Fig. 3). These results are
consistent with the in vivo results with the Y. pestis gcvB
transcriptional fusions.
Regulation of the Y. pestis gcvB gene
The E. coli gcvB gene is activated by GcvA in the presence
of glycine and repressed by GcvA + GcvR in its absence;
this repression is enhanced by the addition of purines
[11]. The regulation of the Y. pestis gcvB gene was tested
with respect to the effects of glycine and purine supple-
mentation to the growth medium and with respect to the
GcvR and GcvA proteins and the GcvB RNAs. For these
experiments we used the λgcvBYp+53::lacZ  fusion to lys-
ogenize appropriate E. coli host strains. The lysogens were
grown in glucose minimal (GM) or GM supplemented
with glycine or inosine to mid-log phase of growth and
assayed for β-galactosidase levels. In the wild-type (WT)
GS162λgcvBYp+53::lacZ lysogen, the addition of glycine to
GM growth medium resulted in an 11.5-fold induction of
β-galactosidase expression, whereas the addition of the
purine inosine resulted in a 2.5-fold repression below the
unsupplemented GM level (Table 2, line 1). In the gcvA
mutant lysogen GS1118λgcvBYp+53::lacZ, the β-galactosi-
dase levels were low and non-inducible by glycine (Table
2, line 2). The addition of inosine had no significant effect
in the gcvA  mutant strain. In the gcvR  mutant lysogen
GS1053λgcvBYp+53::lacZ, the β-galactosidase levels are
constitutively high under all three growth conditions
(Table 2, line 3). The results suggest that activation of the
Y. pestis gcvB gene requires the GcvA protein and that
repression requires the GcvR protein. Whether the nega-
tive regulation by GcvR requires a direct interaction of
GcvR with GcvA as in E. coli [17,18] awaits further inves-
tigation. Furthermore, there appears to be no autoregula-
tion of gcvB by its own sRNA products as the gcvB mutant
lysogen GS1144λgcvBYp+53::lacZ shows normal regulation
of the gcvBYp+53::lacZ fusion (Table 2, line 4).
Y. pestis gcvA encodes an activator protein for gcvB 
expression
Since activation of the Y. pestis gcvBYp+53 fusion in E. coli
was dependent on GcvA (Table 2), we determined if the Y.
pestis gcvA gene also encodes an activator protein for gcvB
expression. We assumed this would be the case, as the E.
coli and Y. pestis GcvA proteins are 88% identical at the
Northern blot analysis of GcvB from Y. pestis strain KIM6 Figure 3
Northern blot analysis of GcvB from Y. pestis strain KIM6. 
Total cell RNA was isolated from strain KIM6 grown in HIB 
at 30°C to an O.D.600 of 0.7 and probed with a 32P-labeled 
GcvB specific DNA probe as described in Methods. Two 
gcvB transcripts of about 206 and 130 nucleotides identified 
are indicated with arrows. Their sizes were determined 
based on their mobilities relative to the mobility of the E. coli 
GcvB RNA and 5S rRNAs (not shown).
Table 1: The Y. pestis gcvB gene encodes two sRNAs. Cells were grown in LB to an OD600 of ~0.5 and assayed for β-galactosidase 
activity [16]. Activity is expressed in Miller units.
Transformant Relevant genotype β-Galactosidase activity
GS162 WT 1 ± 0.1
GS162λgcvBYp+53::lacZ WT 369 ± 40
GS162λgcvBYp+164::lacZ WT 182 ± 7
GS162λgcvBYp+251::lacZ WT 1 ± 0.3BMC Microbiology 2006, 6:52 http://www.biomedcentral.com/1471-2180/6/52
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amino acid sequence level. The Y. pestis gcvA gene was
cloned into plasmid pACYC177 and tested for its ability
to complement an E. coli gcvA mutant. The E. coli strain
GS1132 carries a deletion of the gcvA gene [11]. This strain
was lysogenized with an E. coli λgcvB::lacZ transcriptional
gene fusion and subsequently transformed with the con-
trol plasmid pACYC177, or pACYC177 carrying either the
E. coli or the Y. pestis gcvA gene. The cells were grown in LB
to mid-log phase of growth and assayed for β-galactosi-
dase activity. As reported previously [11], expression of
the E. coli gcvB::lacZ fusion was increased about 400-fold
in the presence of the E. coli gcvA gene (Table 3, line 3).
The  Y. pestis gcvA gene also complemented the E. coli
ΔgcvA strain, restoring gcvB::lacZ expression to nearly the
same level as seen with the E. coli gcvA gene (Table 3, line
4). These results show that the Y. pestis gcvA gene codes for
an activator protein capable of activating expression of an
E. coli gcvB::lacZ fusion.
The Y. pestis gcvR gene encodes a repressor protein for 
gcvB expression
Since deletion of the gcvR gene in E. coli results in consti-
tutive expression of the Y. pestis gcvBYp+53 fusion (Table 2),
we tested if the Y. pestis gcvR gene encodes a repressor for
gcvB expression. We assumed this would be the case, as
the E. coli and Y. pestis GcvR proteins are 75% identical at
the amino acid sequence level. The E. coli strain GS1053
carries a Tn10 element inserted into the gcvR gene [19].
This strain was lysogenized with an E. coli λgcvB::lacZ+50
transcriptional gene fusion [11] and subsequently trans-
formed with the control plasmid pACYC177, or
pACYC177 carrying either the E. coli gcvR gene or the Y.
pestis gcvR gene. The cells were grown in GM media to
mid-log phase of growth and assayed for β-galactosidase
activity. Expression of the E. coli gcvB::lacZ fusion is con-
stitutive in the absence of a functional GcvR protein
(Table 4, lines 1 and 2). The gcvB::lacZ fusion, however,
was repressed in the presence of either pGS601, carrying
E. coli gcvR, or pgcvRYp-p177, carrying Y. pestis gcvR (Table 4,
lines 3 and 4).
In E. coli, the GcvA and GcvR proteins interact to form a
repressor complex [17,18]. The above results suggest that
the Y. pestis GcvR protein interacts with the E. coli GcvA
protein to form a repression complex. We tested if the Y.
pestis gcvA and  gcvR  gene products also likely form a
repressor complex to control expression of an E. coli
gcvB::lacZ fusion. Strain GS1131λgcvB::lacZ carries Δ gcvR
ΔgcvA  mutations. Strain GS1131λgcvB::lacZ  was trans-
formed with plasmid pgcvAYp-p177, pgcvRYp-p322, or both
plasmids. The vectors for pgcvAYp-p177 and pgcvRYp-p322 are
pACYC177 and pBR322, respectively, to insure an excess
of GcvRYp versus GcvAYp. The cells were grown in GM
media + appropriate antibiotics, harvested in mid-log
phase of growth and assayed for β-galactosidase activity.
The Y. pestis gcvA gene complemented the ΔgcvA mutation,
resulting in activation of the gcvB::lacZ fusion (Table 4,
line 7). The Y. pestis gcvR gene complemented the gcvR
mutation, as repression of the gcvB::lacZ fusion occurred
in the pgcvAYp-p177  pgcvRYp-p322  double transformant
(Table 4, line 8). These results suggest that the GcvA and
GcvR proteins likely interact to form a repression complex
in  Y. pestis. In E. coli, GcvA also activates the gcvTHP
operon and GcvA + GcvR repress the operon [17,18].
Table 2: Regulation of the Y. pestis gcvB+53::lacZ transcriptional fusion in E. coli. Cells were grown in GM media with the indicated 
supplements to an OD600 of ~0.5 and assayed for β-galactosidase activity [16]. Activity is expressed in Miller units.
Lysogen Relevant genotype β-galactosidase activity for cells grown in:
GM GM + glycine GM + inosine
GS162λgcvBYp+53::lacZ WT 15 ± 2 173 ± 2 6 ± 3
GS1118λgcvBYp+53::lacZ ΔgcvA 2 ± 1 3 ± 1 2 ± 1
GS1053λgcvBYp+53::lacZ gcvR 620 ± 58 419 ± 13 440 ± 174
GS1144λgcvBYp+53::lacZ ΔgcvB 10 ± 2 140 ± 24 6 ± 2
Table 3: The Y. pestis gcvA gene encodes an activator protein. Cells were grown in LB to an OD600 of ~0.5 and assayed for β-
galactosidase activity [16]. Activity is expressed in Miller units.
Lysogen Relevant genotype β-Galactosidase activity
GS1132λgcvB::lacZ Δ(gcvA gcvB)< 1
GS1132λgcvB::lacZ[pACYC177] Δ(gcvA gcvB)< 1
GS1132λgcvB::lacZ[pGS335] Δ(gcvA gcvB)/gcvAEc 399 ± 22
GS1132λgcvB::lacZ[pgcvAYp-p177] Δ(gcvA gcvB)/gcvAYp 254 ± 21BMC Microbiology 2006, 6:52 http://www.biomedcentral.com/1471-2180/6/52
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Whether the Y. pestis GcvA and GcvR proteins also regulate
the Y. pestis gcvTHP operon, or have additional regulatory
roles, awaits further investigation.
The Y. pestis GcvB RNAs regulate the E. coli and Y. pestis 
dppA genes
The E. coli gcvB gene negatively regulates the dppA and
oppA  genes [11]. In addition, many other genes were
shown to be either negatively or positively regulated by
the GcvB RNAs [11]. Thus, the E. coli GcvB RNAs are likely
global regulators of gene expression. Y. pestis has
homologs of dppA and oppA. To determine if the Y. pestis
GcvB RNAs are regulatory, we transformed an E. coli Δ
gcvB λdppA::lacZ lysogen with pgcvBYp-p322, the transform-
ant and the parent lysogen were grown in LB to mid-log
phase of growth and assayed for β-galactosidase levels. As
expected, deletion of gcvB caused an increase in dppA::lacZ
expression (Table 5, line 2). However, pgcvBYp-p322 com-
plemented the E. coli Δ gcvB mutation, repressing the E.
coli dppA::lacZ fusion (Table 5, line 3). Thus, the Y. pestis
GcvB RNAs regulate the E. coli dppA::lacZ fusion. We then
tested the regulatory activity of the GcvB RNAs in Y. pestis
directly. A single-copy plasmid carrying a Y. pestis
dppA::lacZ fusion was used to transform Y. pestis strain
KIM6 and KIM6Δ gcvB. The transformants were grown in
HIB + AP to mid-log phase of growth and assayed for β-
galactosidase levels. Deletion of the gcvB gene resulted in
a 7.3-fold increase in dppA::lacZ expression (Table 5, com-
pare lines 4 and 5). The results suggest that the Y. pestis
GcvB RNAs are regulatory molecules. However, the mech-
anism of GcvB RNA repression of dppA has not been deter-
mined. Although there is a region of 13–14 nucleotides in
the Y. pestis GcvB RNA that can potentially base-pair with
both the E. coli and Y. pestis dppA mRNAs near their ribos-
ome binding sites, further studies are necessary to deter-
mine if base-pairing of GcvB RNA and dppA mRNA is part
of the regulatory mechanism. Furthermore, in E. coli, the
206 nucleotide GcvB RNA is required for repression of
oppA and dppA [11]. We are constructing a plasmid that
will only produce the 130 nucleotide Y. pestis GcvB RNA
to determine whether the 130 or 206 nucleotide RNA spe-
cies is required for activity in Y. pestis.
Deletion of the Y. pestis gcvB gene slows growth rate and 
alters colony morphology
The KIM6Δ gcvB strain routinely gave smaller colonies on
HIB plates than the parent KIM6 strain. Thus, we investi-
gated the growth of KIM6Δ gcvB to determine the effect of
the  ΔgcvB  mutation on growth rate. The parent strain
KIM6, KIM6ΔgcvB and KIM6ΔgcvB [pgcvBYp-sc] were grown
in HIB broth at 37°C. The generation times were then cal-
culated. The KIM6 generation time at 37°C was 135 ± 15
minutes whereas KIM6ΔgcvB had a generation time of 194
± 20 minutes (Fig. 4). The presence of pgcvBYp-sc  in
KIM6ΔgcvB complemented the gcvB deletion, as the gen-
eration time was reduced to 155 ± 8 minutes, close to the
generation time of strain KIM6. Thus, deletion of the gcvB
gene impairs the ability of Y. pestis to grow as well as the
parent strain on either solid media or in liquid media.
This is in contrast to E. coli gcvB deletion mutants that
Table 5: Regulation of E. coli and Y. pestis dppA::lacZ translational gene fusions by the Y. pestis gcvB gene. Cells were grown in LB (E. 
coli) or in HIB (Y. pestis) at 37°C to an OD600 ~0.5 and assayed for β-galactosidase activity [16]. Activity is expressed in Miller units. The 
parent strains KIM6 and KIM6ΔgcvB grown in HIB at 37°C showed <5 units of β-galactosidase activity.
Lysogen Relevant genotype β-Galactosidase activity
GS162λdppAEc::lacZ WT 103 ± 24
GS1144λdppAEc::lacZ ΔgcvB 554 ± 81
GS1144λdppAEc::lacZ[pgcvBYp-p322] ΔgcvB/gcvBYp 154 ± 32
KIM6[pdppAYp::lacZ] WT 62 ± 13
KIM6ΔgcvB[pdppAYp::lacZ] ΔgcvB 455 ± 7
Table 4: The Y. pestis gcvR gene complements an E. coli gcvR mutation. Cells were grown in GM media to an OD600 of ~0.5 and assayed 
for β-galactosidase activity [16]. Activity is expressed in Miller units.
Lysogen Relevant genotype β-Galactosidase activity
GS1053λgcvB::lacZ GcvR 308 ± 19
GS1053λgcvB::lacZ[pACYC177] GcvR 384 ± 175
GS1053λgcvB::lacZ[pGS601] gcvR/gcvREc 11 ± 1.5
GS1053λgcvB::lacZ[pgcvRYp-p177] gcvR/gcvRYp 14 ± 1.2
GS1131λgcvB::lacZ ΔgcvA ΔgcvR 2.2 ± 0.2
GS1131λgcvB::lacZ[pgcvRYp-p322] ΔgcvA ΔgcvR/gcvRYp 2.8 ± 0.1
GS1131λgcvB::lacZ[pgcvAYp-p177] ΔgcvA ΔgcvR/gcvAYp 393 ± 8
GS1131λgcvB::lacZ[pgcvAYp-177 pgcvRYp-p322] ΔgcvA ΔgcvR/gcvAYp gcvRYp 6.8 ± 0.4BMC Microbiology 2006, 6:52 http://www.biomedcentral.com/1471-2180/6/52
Page 7 of 10
(page number not for citation purposes)
have no observable phenotype. The KIM6Δ gcvB  strain
also showed a different colony morphology from WT
KIM6. WT KIM6 colonies appear smooth and sticky,
whereas the KIM6Δ gcvB colonies appear dry and com-
pact. The presence of pgcvBYp-sc in KIM6ΔgcvB again com-
plemented the gcvB  deletion, as the phenotype was
restored back to the WT colony morphology.
In E. coli, many genes respond to the GcvB RNAs [11]. The
pleiotropic nature of the Y. pestis gcvB deletion suggests
that the Y. pestis GcvB RNAs are likely global regulators as
well. Identification of the specific genes regulated by the
GcvB RNAs that are responsible for the altered phenotype
will allow us to test directly their involvement in virulence
of the organism. In addition, the GcvB sequences and reg-
ulatory regions from bp -90 to +1, which include the puta-
tive GcvA binding sites for activation of gcvB, are 100%
identical in all Yersina pestis strains, and greater than 92%
identical in other Yersinia species. Thus, expression of gcvB
and the regulatory mechanisms of the GcvB RNAs are
likely similar in all Yersinia species.
Conclusion
In summary, the Y. pestis gcvB gene is activated by the
GcvA protein and repressed by the GcvR protein. The gcvB
gene encodes two sRNAs that have regulatory activity,
repressing dppA expression. A gcvB deletion is pleiotropic,
suggesting that the GcvB RNAs possibly serve as global
regulators in Y. pestis.
Methods
Bacterial strains, plasmids and phage
Bacterial strains, plasmids and phage used in this study
are listed in Table 6 or are described in the text.
Media
For E. coli strains, the complex medium used was LB [16]
and the defined medium used was the minimal salts of
Vogel and Bonner [20] supplemented with 0.4% glucose.
GM media was always supplemented with 50 μg ml-1 of
phenylalanine and 1 μg ml-1 of vitamin B1, since all E. coli
strains carry pheA, thi mutations. Where indicated, glycine
and inosine were added at 300 μg ml-1 and 50 μg ml-1,
respectively. For Y. pestis strains, HIB was used [21]. Agar
was added at 1.5% to make solid media. Antibiotics were
added at the following concentrations: AP, 150 μg ml-1 for
multi-copy plasmids and 50 μg ml-1 for single-copy plas-
mids; chloramphenicol (CM), 20μg ml-1; tetracycline
(TC), 10 μg ml-1.
β-galactosidase assays
β-galactosidase assays were performed on mid-log phase
cells (OD600~0.5) as described by Miller [16]. Each exper-
iment was repeated at least twice, with each sample
assayed in triplicate.
DNA manipulation
Plasmid DNA was isolated using Qiagen Miniprep kits as
described by the manufacturer (Qiagen). Restriction
enzyme digestions and DNA ligations were carried out
according to the manufacturer (New England Biolabs).
DNA sequencing was performed by the University of Iowa
DNA Core Facility.
PCR
PCR reactions were performed in 100 μl volumes. Each
reaction mixture contained 10 μl 10 × polymerase buffer,
10 μl 10 × dNTPs (0.2 mM each), 5 μl Y. pestis DNA (~15
ng), 100 pmoles of forward and reverse primers designed
specifically for each reaction, 1 μl of vent polymerase, and
sterile water to bring the volume to 100 μl. PCR reactions
were carried out under the following conditions: 5 min
pre-incubation at 95°C, and then 30 cycles of 95°C for 30
sec, 45°C for 30 sec, and 72°C for 2 min.
RNA extraction and Northern blot analysis
Y. pestis KIM6 was grown in HIB at 30°C to an O.D.600 of
0.7, the cells collected for 1 minute in a microcentrifuge
and immediately frozen at -70°C. Total cellular RNA was
isolated using the MasterPure™ RNA purification kit (Epi-
center). The final RNA pellet was re-suspended in water
treated with diethyl pyrocarbonate and kept at -70°C. The
RNA concentration was measured with a spectrophotom-
eter at 260 nm. RNA (10 μg) was separated through a
1.5% formaldehyde gel and blotted on to a Biodyne Plus
Effects of the ΔgcvB mutation on Y. pestis growth rates Figure 4
Effects of the ΔgcvB mutation on Y. pestis growth rates. Y. pes-
tis strains KIM6 (), KIM6ΔgcvB (■), and KIM6ΔgcvB[pgcvBYp-
sc] (▲) were grown in HIB (+ AP for the pgcvBYp-sc trans-
formant) at 37°C. The experiment was repeated three times. 
The curves show the results of a representative experiment.
0
50
100
150
200
250
Time (min)
6
0
1
2
0
1
8
0
2
4
0
3
0
0
3
6
0
4
2
0
4
8
0
5
4
0
6
0
0
K
l
e
t
t
u
n
i
t
sBMC Microbiology 2006, 6:52 http://www.biomedcentral.com/1471-2180/6/52
Page 8 of 10
(page number not for citation purposes)
Membrane (ISC BioExpress). The blot was hybridized
with a PCR generated DNA fragment from bp +1 to +198
of the Y. pestis gcvB gene and 32P-labeled using the Redip-
rimeTM II Random Prime Labeling System (Amersham
Biosciences). Hybridization of the blot was at 58°C as
described [22].
Construction of gcvA, gcvB and gcvR plasmids
The Y. pestis gcvB gene was cloned as follows. PCR primer
YP-GCVB1F has an artificial EcoRI site and is complemen-
tary to the Y. pestis KIM6 DNA sequence beginning 114
bases upstream of the gcvB transcription start site. PCR
primer YP-GCVB2R has an artificial HindIII site and is
complementary to the Y. pestis DNA sequence beginning
45 bases downstream of the gcvB transcriptional termina-
tion site t2 (Fig. 1). Following PCR amplification, using Y.
pestis chromosomal DNA as template, the amplified DNA
was digested with EcoRI and HindIII, the 400 bp fragment
carrying gcvB isolated from a 1% agarose gel and ligated
into the EcoRI and HindIII sites of plasmid pBR322 [23],
generating plasmid pgcvBYp-p322. The Y. pestis gcvA and
gcvR genes were cloned using a similar strategy. For gcvA,
both the forward and reverse primers contained artificial
HindIII sites complementary to the Y. pestis sequence
beginning 111 bases upstream of the gcvA transcription
start site and 349 bases downstream of the gcvA transla-
tion stop codon. For gcvR, both the forward and reverse
primers contained artificial HindIII sites complementary
to the Y. pestis sequence beginning 313 bases upstream of
the gcvR transcription start site and 198 bases downstream
of the gcvR translation stop codon. The PCR amplified
fragments were cloned into the HindIII site of plasmid
pACYC177 [24], generating plasmids pgcvAYp-p177  and
pgcvRYp-p177. In a second construct of gcvR, both the
upstream and downstream primers contained artificial
EcoRI sites and the PCR amplified fragment was cloned
into the EcoRI site of plasmid pBR322, generating plasmid
pgcvRYp-p322. Each gene was sequenced at the University of
Iowa DNA Core Facility to verify that no bp changes were
introduced during the PCR amplification procedure.
Construction of lacZ gene fusions
Three different transcriptional gene fusions of gcvB to the
lacZ gene were constructed by PCR synthesis of fragments
with common BamHI termini 128 bp upstream of the
gcvB transcription start site and 3 different fusion points
within  gcvB. In plasmid pBYp+53::lacZ, the downstream
PCR primer hybridized to the gcvB sequence beginning at
Table 6: Bacterial strains, plasmids and phage. All E. coli strains listed also carry Δ(argF-lac)U169, pheA905, thi, araD129, rpsL150, relA1, 
deoC1, flb5301, ptsF25 and rpsR mutations.
Strains/plasmids/phage Relevant genotype Source/reference
Strains*
GS162 WT This laboratory
GS1053 gcvR::Tn10 [19]
GS1118 ΔgcvA:ΣaadA This laboratory
GS1131 ΔgcvA:ΣaadA ΔgcvR:ΣKNR [11]
GS1132 Δ(gcvA gcvB):ΣaadA [11]
GS1144 ΔgcvB:ΣCMR This laboratory
KIM6 lcr- [31]
KIM6ΔgcvB ΔgcvB:ΣCMR This study
Plasmid
pGS366 Single-copy translational lacZ fusion vector This laboratory
pgcvBYp-p322 Carries Y. pestis gcvB in pBR322 This study
pgcvBYp-sc Carries Y. pestis gcvB in a single-copy vector This study
pgcvAYp-p177 Carries Y. pestis gcvA in pACYC177 This study
pgcvRYp-p177 Carries Y. pestis gcvR in pACYC177 This study
pgcvRYp-p322 Carries Y. pestis gcvR in pBR322 This study
pdppAYp::lacZ Y. pestis dppA::lacZ fusion in pGS366 This study
pGS335 Carries E. coli gcvA in pACYC177 This lab
pGS601 Carries E. coli gcvR in pACYC177 This lab
Phage
λdppA::lacZ λgt2 with E. coli dppA::lacZ translational fusion [11]
λgcvB::lacZ λgt2 with E. coli gcvB+50::lacZ transcriptional 
fusion
[11]
λgcvBYp+53::lacZ λgt2 with Y. pestis gcvB+53::lacZ transcriptional 
fusion
This study
λgcvBYp+164::lacZ λgt2 with Y. pestis gcvB+164::lacZ transcriptional 
fusion
This study
λgcvBYp+251::lacZ λgt2 with Y. pestis gcvB+251::lacZ transcriptional 
fusion
This studyBMC Microbiology 2006, 6:52 http://www.biomedcentral.com/1471-2180/6/52
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bp +53 relative to the predicted transcription start site
(+1) of gcvB (Fig. 1). A synthetic HindIII site was included
at the end of the primer to allow the cloning of the 202
bpBamHI-HindIII fragment into the BamHI-HindIII sites
of the lacZ transcriptional reporter plasmid pQF50 [25].
Plasmids pBYp+164::lacZ  and pBYp+251::lacZ  were con-
structed similarly except that the downstream primers
used for PCR synthesis hybridized to the gcvB sequence
beginning at bp +164 and +251 (Fig. 1), and the 313 and
400 bp fragments produced were cloned into the BamHI-
HindIII sites of pQF50. Each fusion was sequenced at the
University of Iowa DNA Core Facility to verify that the
fusions were at the correct sites and that no bp changes
were introduced during the PCR amplification procedure.
Each gcvB transcriptional fusion was then subcloned into
plasmid pMC1403 [26], generating plasmids
pgcvBYp+53::lacZ, pgcvBYp+164::lacZ  and pgcvBYp+251::lacZ,
and subsequently transferred to phage λgt2 [27] as
described [11], generating phage λgcvBYp+53::lacZ,
λgcvBYp+164::lacZ and λgcvBYp+251::lacZ, respectively.
A single-copy Y. pestis dppAYp::lacZ  translational fusion
was constructed in two steps. First, a dppAYp::lacZ transla-
tional fusion was constructed using an upstream PCR
primer with an EcoRI site complementary to the Y. pestis
DNA sequence beginning 300 bps upstream of the dppA
transcription initiation site and a downstream primer that
contains an artificial SmaI site and that hybridizes to the
dppA sequence after the 15th codon relative to the transla-
tion initiation site. The 611 bp dppA fragment was cloned
into the EcoRI and SmaI sites of the lacZ  translational
reporter plasmid pMC1403. The fusion was sequenced at
the University of Iowa DNA Core Facility to verify that the
fusion was at the correct site and that no bp changes were
introduced during the PCR amplification procedure. The
dppAYp::lacZ fusion, along with the lacY and lacA genes,
was then cloned into the single-copy plasmid pGS366,
designated pdppAYp::lacZ.
Chromosomal deletion of gcvB
A gcvB deletion was constructed on the Y. pestis chromo-
some essentially as described [28]. Y. pestis strain KIM6
was transformed with plasmid pKD46, which encodes the
Red recombinase of phage λ[28]. PCR products were then
generated using two primers with 50 nt extensions that are
complementary to sequences that flank the gcvB gene and
20 nt priming sequences that are complementary to the
template plasmid pKD32 and that flank the CMR gene and
the FLP recognition sequence [28]. The PCR fragment was
gel purified and used to transform Y. pestis KIM6 [pKD46].
The cells were plated on HIB plates with CM and CMR
recombinants were selected. One CMR recombinant was
single colony purified, chromosomal DNA was prepared,
and PCR analysis was used to verify that the gcvB gene was
deleted and replaced with the CMR marker. The pKD46
plasmid is a temperature sensitive replicon and was cured
by growth at 37°C [28]. The strain was designated KIM6Δ
gcvB.
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